Literature DB >> 26222682

Bioorthogonal SERS Nanoprobes for Mulitplex Spectroscopic Detection, Tumor Cell Targeting, and Tissue Imaging.

Junzhou Wu1, Duanwei Liang1, Qingqing Jin1, Jie Liu2, Meiling Zheng2, Xuanming Duan2, Xinjing Tang3.   

Abstract

A surface-enhanced Raman scattering (SERS) technique shows extraordinary features for a range of biological and biomedical applications. Herein, a series of novel bioorthogonal SERS nanoprobes were constructed with Gold nanoflower (AuNF) and Raman reporters, the signals of which were located in a Raman-silent region of biological samples. AS1411 aptamer was also co-conjugated with AuNF through a self-assembled monolayer coverage strategy. Multiplex SERS imaging using these nanoprobes with three different bioorthogonal small-molecule Raman reporters is successfully achieved with high multiplexing capacity in a biologically Raman-silent region. These Raman nanoprobes co-conjugated with AS1411 showed high affinity for tumor cells with overexpressed nucleolin and can be used for selective tumor cell screening and tissue imaging.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  AS1411; Raman spectroscopy; aptamers; bioorthogonality; cell targeting; nanoprobes

Mesh:

Substances:

Year:  2015        PMID: 26222682     DOI: 10.1002/chem.201501942

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  2 in total

1.  Alkyne- and Nitrile-Anchored Gold Nanoparticles for Multiplex SERS Imaging of Biomarkers in Cancer Cells and Tissues.

Authors:  Mingmin Li; Jianzhen Wu; Mengtian Ma; Zhichao Feng; Ze Mi; Pengfei Rong; Dingbin Liu
Journal:  Nanotheranostics       Date:  2019-02-08

2.  SERRS multiplexing with multivalent nanostructures for the identification and enumeration of epithelial and mesenchymal cells.

Authors:  Lucio Litti; Andrea Colusso; Marcella Pinto; Erlis Ruli; Alessia Scarsi; Laura Ventura; Giuseppe Toffoli; Marco Colombatti; Giulio Fracasso; Moreno Meneghetti
Journal:  Sci Rep       Date:  2020-09-25       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.